
News|Articles|October 1, 2005
Pipeline Preview
Nelarabine (Arranon, GlaxoSmithKline) injection for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in pediatric and adult patients whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.
Advertisement
Recommendations for accelerated approval
Recommendations for approval
Orphan drug designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patient-facing EHR tool improves lung cancer screening identification
2
How California is rewriting the PBM playbook
3
Study highlights high costs, treatment challenges for older adults with HER2-positive advanced gastric cancer
4
New therapies on the way to lower Lp(a), a cardiovascular risk factor
5





















































